Visionary Holdings Signs Cooperation Agreement with Strategic Investment Partner for Proposed US$20 Million Investment in Qingdao Anti-Aging Project

Core Viewpoint - Visionary Holdings Inc. has entered into a strategic investment agreement for a US$20 million anti-aging project in Qingdao, China, aimed at establishing a research center and health management chain [1][2]. Investment Agreement Details - The agreement involves the establishment of a project company to operate the collaboration, focusing on cell therapy and biologics [2]. - The investment will be made in two phases, with the first phase comprising three milestone-based payments: 30% upon project company establishment, 40% after research center renovation, and 30% after the first flagship center opens [3]. - A second-phase investment of US$10 million is planned, contingent on the project's development progress [3]. Support Measures - The agreement includes various support measures such as local resource coordination, preferential office and R&D space, talent housing support, and assistance with business registration and approvals [4]. - There is also a plan for a Sino-U.S. international life sciences incubator to attract participants in the industry [4]. Valuation and Ownership Framework - The project's pre-investment valuation will reference the value of the Company's intellectual property and cash capital, with equity interest percentages to be finalized after due diligence [5]. - The project company will operate under exclusive technology authorization, with designated management and technical personnel [6]. Operational Goals - The project aims to achieve profitability for the first anti-aging center within one year of investment completion and to secure a leading market position within two years [6]. - The CEO of Visionary emphasized the structured framework of the agreement, including funding, milestones, and regional support [6].